Fund+
Overview
Fund+ invests in life sciences companies in Belgium.
Investment Focus
- Active in life sciences (primary focus on therapeutics, not excluding diagnostics and medical devices)
- In an advanced development stage (first round and subsequent financing)
- Experienced management team respecting highest ethical values
- Solid business plan
- Invest in Europe, with a focus on Belgium
Portfolio Companies
Get the full list of 54,000+ investors
Fund+ and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Fund+
What sectors does Fund+ invest in?
Fund+ invests in Life Sciences, Digital Health, Medical Devices, Diagnostics and Biotechnology, and is based in Flemish Brabant, Belgium. Fund+ is listed as a vc in the ConnectSafely investor database.
What stage does Fund+ invest at?
Fund+ backs companies at Series A and Series B, writing cheques of 5M - 15M.
Which regions does Fund+ invest in?
Fund+ invests across Germany, France, Spain and Belgium.
What companies has Fund+ invested in?
Fund+'s portfolio includes Tubulis, Ona Therapeutics, Indigo Diabetes, TargED Biopharmaceuticals, AstriVax, Minoryx Therapeutics, Cardior Pharmaceuticals and Horama.
Last updated · Source: ConnectSafely investor database
